<a href="https://laohu8.com/S/VSEE">VSee Health</a> Inc. Announces Restatement of Financial Statements Due to Significant Reporting Errors and Internal Control Weaknesses
VSee Health Inc. has announced a regulatory issue concerning the reliability of its previously issued financial statements. The company identified multiple errors in its consolidated financial statements for the year ended December 31, 2023, and several interim periods in 2023 and 2024. These errors include the failure to account for sales and use taxes, incorrect revenue and expense recognition, and misclassification of equity interests, among others. Consequently, these financial statements should no longer be relied upon and will be restated in the company's 2024 Form 10-K. VSee Health's management has acknowledged material weaknesses in its internal control over financial reporting and ineffective disclosure controls, which will be detailed further in the upcoming report. The company has discussed these issues with its independent registered public accounting firm, WithumSmith+Brown, PC.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VSee Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-084843), on August 28, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。